tiprankstipranks
Trending News
More News >
ImmunityBio (IBRX)
NASDAQ:IBRX
Advertisement

ImmunityBio (IBRX) Revenue

Compare
1,537 Followers

ImmunityBio Revenue

ImmunityBio had a revenue of 26.43M in the quarter ending Jun 30, 2025, with 59.99%. This bring the company's revenue in the last twelve months to 56.60M, Decreased 81.28%. In the fiscal year ending Dec 31, 2024, ImmunityBio had annual revenue of 14.74M with 2270.58% growth.
Revenue (ttm)
56.60M
Revenue Growth
4227.22%
P/S Ratio
153.22
Revenue/Employee
$21,975
Employees
671
Market Cap
$2.26B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
14.74M14.12M+2,270.58%
Dec 31, 2023
622.00K382.00K+159.17%
Dec 31, 2022
240.00K-694.00K-74.30%
Dec 31, 2021
934.00K329.00K+54.38%
Dec 31, 2020
605.00K-1.60M-72.52%
Dec 31, 2019
2.20M2.15M+4,585.11%
Dec 31, 2018
47.00K2.00K+4.44%
Dec 31, 2017
45.00K1.00K+2.27%
Dec 31, 2016
44.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis